GABRA3 and breast carcinoma: ADAR1-edited Gabra3 was only in non-invasive breast cancer and showed that edited Gabra3 reduced the abundance of wild-type Gabra3 on the cell surface and inhibited AKT activation, thereby suppressing breast cancer cell invasion and metastasis (Gumireddy et al., 2016).